Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Dolutegravir Nrtis'

Dolutegravir Nrtis published presentations and documents on DocSlides.

Switch to DRV/r

Switch to DRV/r

  • mitsue-stanley
  • 16 Slides

monotherapy. MONOI. MONET. PROTEA. DRV600. Design...

2013 Asilomar HIV Medical Update

2013 Asilomar HIV Medical Update

  • luanne-stotts
  • 74 Slides

David Spach, MD. Clinical Director, Northwest AET...

ART Resistance and Second Line Regimens

ART Resistance and Second Line Regimens

  • calandra-battersby
  • 0 Slides

Learning Objectives. Understand when to switch to...

Antiretroviral Updates:

Antiretroviral Updates:

  • tatyana-admore
  • 0 Slides

New Treatments for HIV. C. Ryan Tomlin, . Pharm.D...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

  • celsa-spraggs
  • 0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

MPP LICENCES AND OPPORTUNITIES FOR INTRODUCTION OF NEW PRODUCTS AND FORMULATIONS

  • cheryl-pisano
  • 0 Slides

Esteban Burrone, . July 2017. THE MEDICINES PATEN...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

HIV Pharmacotherapy Focused Update

HIV Pharmacotherapy Focused Update

  • yoshiko-marsland
  • 0 Slides

Drew Lambert, . PharmD. lambertd@husson.edu. Huss...

Updated WHO Treatment Guidelines &

Updated WHO Treatment Guidelines &

  • mitsue-stanley
  • 0 Slides

Data . from other . cohorts and . regions to guid...

HIV 2015-2016: New Agents, New Strategies

HIV 2015-2016: New Agents, New Strategies

  • ellena-manuel
  • 0 Slides

Learning Objectives. EARLY VS DEFERRED ART. The C...

New regimen for $75 a year

New regimen for $75 a year

  • tawny-fly
  • 0 Slides

New pricing agreement will speed up access to gen...

Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah

Working Group on Modelling Potential Responses to High Levels of pre-ART Drug Resistance in Sub-Sah

  • debby-jeon
  • 0 Slides

HIV Drug Resistance (HIVDR) and Antimicrobial Res...

New Antiretrovirals for the Treatment

New Antiretrovirals for the Treatment

  • alida-meadow
  • 0 Slides

of HIV. . Convenience, tolerability, simplicity....

Modifying Therapy in the Treatment-experienced Patient:

Modifying Therapy in the Treatment-experienced Patient:

  • yoshiko-marsland
  • 0 Slides

When should it be done?. Professor of Medicine. U...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

  • myesha-ticknor
  • 0 Slides

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

Essentials for Optimal Care of HIV Patients

Essentials for Optimal Care of HIV Patients

  • marina-yarberry
  • 0 Slides

Evidence-Based Approaches. Simply Speaking. ®. ...

Ellen G. Chadwick, MD Professor of Pediatrics

Ellen G. Chadwick, MD Professor of Pediatrics

  • mitsue-stanley
  • 0 Slides

Northwestern University Feinberg School of Medici...

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

ACTHIV 2018: A State-of-the-Science Conference for Frontline Health Professionals

  • phoebe-click
  • 0 Slides

ACTIVITY CODE . TD342. Antiretroviral Medications...

Dolutegravir monotherapy

Dolutegravir monotherapy

  • alexa-scheidler
  • 15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

ART in Women and Contraception: InSTIs

ART in Women and Contraception: InSTIs

  • olivia-moreira
  • 52 Slides

ART in Women and Contraception: InSTIs , Comorbi...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

  • alida-meadow
  • 22 Slides

Heather Watts MD Director of HIV Prevention, Pro...

Paediatric ARV Drug Optimization 3 Review Summary report &

Paediatric ARV Drug Optimization 3 Review Summary report &

  • neoiate
  • 15 Slides

*\n\b...

Interactive ART Cases From the Clinic: Is There One Right Answer?

Interactive ART Cases From the Clinic: Is There One Right Answer?

  • megan
  • 44 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

  • brown
  • 34 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Zidovudine Retrovir AZT Class Zidovudine is a thymidine analog

Zidovudine Retrovir AZT Class Zidovudine is a thymidine analog

  • mackenzie
  • 2 Slides

Disease state based dosing: �Clcr 10 mL/min...

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

Effect of dolutegravir on folate and vitamin B12 status among HIV-infected children and adolescents

  • ethlyn
  • 9 Slides

Linda Barlow-Mosha*. 1. , Grace Miriam . Ahimbisib...

Lopinavir -RTV + NVP +

Lopinavir -RTV + NVP +

  • thomas
  • 6 Slides

2 NRTIs in Treatment-Experienced. M97-765 Trial. L...

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

Dolutegravir plus Rilpivirine as Maintenance Dual Therapy

  • quinn
  • 13 Slides

SWORD-1 . and SWORD-. 2. Dolutegravir plus Rilpivi...

Dolutegravir-Lamivudine (

Dolutegravir-Lamivudine (

  • audrey
  • 43 Slides

Dovato. ). Last Updated: November 28, 2022. Prepar...

Optimizing HIV treatment

Optimizing HIV treatment

  • anderson
  • 26 Slides

Professor Francois Venter. Ezintsha, University of...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

  • jasmine
  • 15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

LPV-RTV + 3TC vs. LPV-RTV + 2 NRTIs in

  • lucy
  • 7 Slides

Virologically. Suppressed. OLE Trial. LPV-RTV + ....

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

Switching Antiretroviral Therapy (ART) in Your African American Patients: When and How

  • taylor
  • 29 Slides

Supported by an educational grant from Gilead Scie...

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

Dolutegravir + 2 NRTIs versus Darunavir + RTV + 2 NRTIs

  • roxanne
  • 9 Slides

FLAMINGO. Dolutegravir + 2 NRTIs versus Darunavir ...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

  • winnie
  • 12 Slides

by Baseline NRTI Resistance . and Second-Line NRTI...

Dolutegravir vs. Raltegravir

Dolutegravir vs. Raltegravir

  • zoe
  • 9 Slides

SPRING-2 Study. Dolutegravir. versus Raltegravir....

A nti- R etroviral T herapy Basics

A nti- R etroviral T herapy Basics

  • caroline
  • 85 Slides

E Duke. https://www.hiv.uw.edu/page/treatment/drug...

Dolutegravir ( Tivicay )

Dolutegravir ( Tivicay )

  • brown
  • 100 Slides

Prepared by:. Brian R. Wood, MD. David H. Spach, M...

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

Switch NRTIs to Tenofovir DF-Emtricitabine or Abacavir-Lamivudine

  • kylie
  • 7 Slides

STEAL. Switch NRTIs to Tenofovir DF-Emtricitabine ...

Update from CROI 2023: Snippets from Seattle

Update from CROI 2023: Snippets from Seattle

  • scarlett
  • 28 Slides

Judith S. Currier, MD, MSc. Professor of Medicine....

Copyright © 2024 DocSlides. All Rights Reserved